Matches in SemOpenAlex for { <https://semopenalex.org/work/W4323856825> ?p ?o ?g. }
- W4323856825 abstract "The permeability of the Biopharmaceutics Classification System (BCS) class III drugs are low, and their oral bioavailability needs to be improved. In this study, we attempted to design oral formulations containing famotidine (FAM) nanoparticles to overcome the limitations of BCS class III drugs. Dispersions containing FAM nanoparticles with a particle size of approximately 50-220 nm were produced by the bead-milling treatment. Moreover, we succeeded in preparing an orally disintegrating tablet containing FAM nanoparticles using the dispersions described above, additives (D-mannitol, polyvinylpyrrolidone, and gum arabic), and freeze-dry treatment (FAM-NP tablet). The FAM-NP tablet was disaggregated 3.5 s after addition to purified water, and the FAM particles in the redispersion of the FAM-NP tablet stored for 3 months were nano-sized (141 ± 6.6 nm). The ex-vivo intestinal penetration and in vivo absorption of FAM in rats applied with the FAM-NP tablet were significantly higher than those in rats applied with the FAM tablet containing microparticles. In addition, enhanced intestinal penetration of the FAM-NP tablet was attenuated by an inhibitor of clathrin-mediated endocytosis. In conclusion, the orally disintegrating tablet containing FAM nanoparticles improved low mucosal permeability and low oral bioavailability and overcame these issues of BCS class III drugs as oral formulations." @default.
- W4323856825 created "2023-03-11" @default.
- W4323856825 creator A5004862834 @default.
- W4323856825 creator A5037222124 @default.
- W4323856825 creator A5038437278 @default.
- W4323856825 creator A5045418527 @default.
- W4323856825 creator A5049278001 @default.
- W4323856825 creator A5054296045 @default.
- W4323856825 creator A5057747415 @default.
- W4323856825 creator A5068116481 @default.
- W4323856825 creator A5068856202 @default.
- W4323856825 date "2023-03-10" @default.
- W4323856825 modified "2023-09-26" @default.
- W4323856825 title "Orally disintegrating tablets containing famotidine nanoparticles provide high intestinal absorbability via the energy-dependent endocytosis pathway" @default.
- W4323856825 cites W1533933224 @default.
- W4323856825 cites W1976224541 @default.
- W4323856825 cites W1977603484 @default.
- W4323856825 cites W1980016552 @default.
- W4323856825 cites W1984257229 @default.
- W4323856825 cites W2011530145 @default.
- W4323856825 cites W2013852604 @default.
- W4323856825 cites W2016431125 @default.
- W4323856825 cites W2022589148 @default.
- W4323856825 cites W2032294778 @default.
- W4323856825 cites W2032503242 @default.
- W4323856825 cites W2032855829 @default.
- W4323856825 cites W2075215328 @default.
- W4323856825 cites W2077830075 @default.
- W4323856825 cites W2084752491 @default.
- W4323856825 cites W2111421554 @default.
- W4323856825 cites W2120826143 @default.
- W4323856825 cites W2130558302 @default.
- W4323856825 cites W2133061394 @default.
- W4323856825 cites W2334770279 @default.
- W4323856825 cites W2548150499 @default.
- W4323856825 cites W2614141273 @default.
- W4323856825 cites W2795043036 @default.
- W4323856825 cites W2912396451 @default.
- W4323856825 cites W2975943876 @default.
- W4323856825 cites W2997061680 @default.
- W4323856825 cites W3014915691 @default.
- W4323856825 cites W3189798325 @default.
- W4323856825 cites W3197501744 @default.
- W4323856825 cites W4210969432 @default.
- W4323856825 cites W4246739901 @default.
- W4323856825 doi "https://doi.org/10.3389/fbioe.2023.1167291" @default.
- W4323856825 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36970629" @default.
- W4323856825 hasPublicationYear "2023" @default.
- W4323856825 type Work @default.
- W4323856825 citedByCount "0" @default.
- W4323856825 crossrefType "journal-article" @default.
- W4323856825 hasAuthorship W4323856825A5004862834 @default.
- W4323856825 hasAuthorship W4323856825A5037222124 @default.
- W4323856825 hasAuthorship W4323856825A5038437278 @default.
- W4323856825 hasAuthorship W4323856825A5045418527 @default.
- W4323856825 hasAuthorship W4323856825A5049278001 @default.
- W4323856825 hasAuthorship W4323856825A5054296045 @default.
- W4323856825 hasAuthorship W4323856825A5057747415 @default.
- W4323856825 hasAuthorship W4323856825A5068116481 @default.
- W4323856825 hasAuthorship W4323856825A5068856202 @default.
- W4323856825 hasBestOaLocation W43238568251 @default.
- W4323856825 hasConcept C112705442 @default.
- W4323856825 hasConcept C1491633281 @default.
- W4323856825 hasConcept C150903083 @default.
- W4323856825 hasConcept C155672457 @default.
- W4323856825 hasConcept C171250308 @default.
- W4323856825 hasConcept C178790620 @default.
- W4323856825 hasConcept C181389837 @default.
- W4323856825 hasConcept C185592680 @default.
- W4323856825 hasConcept C192562407 @default.
- W4323856825 hasConcept C202751555 @default.
- W4323856825 hasConcept C207001950 @default.
- W4323856825 hasConcept C26291073 @default.
- W4323856825 hasConcept C2778445172 @default.
- W4323856825 hasConcept C2780077769 @default.
- W4323856825 hasConcept C2781263782 @default.
- W4323856825 hasConcept C2781430271 @default.
- W4323856825 hasConcept C28005876 @default.
- W4323856825 hasConcept C55493867 @default.
- W4323856825 hasConcept C71924100 @default.
- W4323856825 hasConcept C86803240 @default.
- W4323856825 hasConcept C98274493 @default.
- W4323856825 hasConceptScore W4323856825C112705442 @default.
- W4323856825 hasConceptScore W4323856825C1491633281 @default.
- W4323856825 hasConceptScore W4323856825C150903083 @default.
- W4323856825 hasConceptScore W4323856825C155672457 @default.
- W4323856825 hasConceptScore W4323856825C171250308 @default.
- W4323856825 hasConceptScore W4323856825C178790620 @default.
- W4323856825 hasConceptScore W4323856825C181389837 @default.
- W4323856825 hasConceptScore W4323856825C185592680 @default.
- W4323856825 hasConceptScore W4323856825C192562407 @default.
- W4323856825 hasConceptScore W4323856825C202751555 @default.
- W4323856825 hasConceptScore W4323856825C207001950 @default.
- W4323856825 hasConceptScore W4323856825C26291073 @default.
- W4323856825 hasConceptScore W4323856825C2778445172 @default.
- W4323856825 hasConceptScore W4323856825C2780077769 @default.
- W4323856825 hasConceptScore W4323856825C2781263782 @default.
- W4323856825 hasConceptScore W4323856825C2781430271 @default.
- W4323856825 hasConceptScore W4323856825C28005876 @default.
- W4323856825 hasConceptScore W4323856825C55493867 @default.